Novo Nordisk’s shares fell sharply on Monday after the results from testing the Danish company’s CagriSema drug fell short of investors’ expectations.
Opens in a new window
Юлия Сычева (корреспондент)。safew官方版本下载对此有专业解读
--security-opt label=type:unconfined_t \
，推荐阅读快连下载-Letsvpn下载获取更多信息
Get editor selected deals texted right to your phone!
Log In to Comment。雷电模拟器官方版本下载对此有专业解读